Market open · Delayed intraday data · 12:50 PM ET
Last update: Jul 20, 2026, 12:32 PM ET
Medpace Holdings, Inc.
$534.54 0.59% today
Market Open

Why Medpace Holdings, Inc. (MEDP) stock moved

Updated Jul 20, 2026

Medpace Holdings, Inc. (MEDP) shares fell 0.6% to $534.54 as of July 20, 2026, a slight decline from the prior close of $537.73. BestStocks flagged the session as a major change for MEDP. Below, we break down what changed for MEDP, why it matters for investors, how the stock reacted, and the catalysts on the calendar.

What happened

MEDP fell 0.6% to $534.54

MEDP moved -2.62% from $546.29 to $531.99 on 2026-07-08. Monitor next session.

This summary describes the catalyst and move as first detected on Jul 8, 2026, 4:40 PM EDT; the stock has continued trading since, so the current price and percentage move (shown above) may be larger or smaller than the figures here.
RiskWeak confidence
Rel. volume
0.3×
Below Avg
Vs peers
No comparable peers
Market cap
$15.3B
NASDAQ Global Select
Analyst target
$503
-5.9% vs price
Price chart
Jun 22 – Jul 20
VVVV$455$510$566Jun 22Jun 29Jul 7Jul 13Jul 20
E earnings
F filing
A analyst
V/N other
click a marker to highlight
Change events — click to jump to details

What it means for Medpace Holdings, Inc. investors

For Medpace Holdings, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive price momentum; Positive price momentum. Weighing against that: Negative session, down 0.6%; MEDP moved -2.62% from $546.29 to $531.99 on 2026-07-08. Wall Street's consensus price target sits at $503.00, implying -5.9% downside from $534.54. Over the past 90 days analysts logged 0 upgrades and 2 downgrades. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 2 days out, the next report is the most likely near-term test of the move.

MEDP price reaction

MEDP last traded at $534.54, down $3.19 (-0.59%) from the previous close of $537.73. The session traded on 0.3× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $455.66 and $565.09, and it currently sits about 72% of the way up that band.

Bullish and bearish analyst opinions on Medpace Holdings, Inc. (MEDP)

The consensus analyst price target on Medpace Holdings, Inc. (MEDP) is $503.00, 5.9% below the recent $534.54. Over the past 90 days analysts logged 0 upgrades, 5 maintains, and 2 downgrades. Here is how the bullish and bearish cases on MEDP line up.

The bullish case

  • The Street's most bullish target is $586.00 (+9.6%).
  • Positive price momentum.

The bearish case

  • The consensus analyst price target of $503.00 sits 5.9% below the recent $534.54, so the average target sees limited room to run.
  • The most bearish analyst target is $400.00 (-25.2%).
  • 2 analyst downgrades in the past 90 days, most recently Baird to Neutral (2026-07-08).
  • Negative session, down 0.6%.
  • MEDP moved -2.62% from $546.29 to $531.99 on 2026-07-08.
Bull vs bear balanceNeutral / Mixed
BearishNeutralBullish

Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.

Analyst price targets and ratings are FMP consensus figures as of Jul 20, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.

Analyst expectations
Consensus target: $503-5.9%
= 5 maintains2 downgrades
Mizuho maintained Outperform · 2026-07-13
SEC filings watch
8-K2026-06-04
Material event — review for impact
high
8-K2026-05-19
Material event — review for impact
high
10-Q2026-04-23
Quarterly financial results
medium
8-K2026-04-22
Material event — review for impact
high
Peer context
MEDP-0.6%

Previous notable changes for MEDP

Activity2026-07-06+1.3%via zacks.com
Medpace gained 1.04% to $563.39, though volume remained below average at 0.45x expected levels for this stage of the session. No concrete catalyst from earnings, guidance, or deal news was found today; the modest move occurred amid a Zacks outlook note (2026-07-06) flagging risks from rising cancellations and softer proposal activity, offset by potential strength in backlog quality and metabolic demand.
Activity2026-07-02+2.6%via zacks.com
MEDP rose 0.88% intraday to $551.03. This follows a +2.64% gain on the prior trading day (July 1, 2026) when the stock closed at $543.57.
Valuation2026-07-01+2.6%via Yahoo Finance
Medpace reported Q1 2026 earnings with EPS of $4.28 (beating forecasts by 9.18%) and revenue of $706.6 million (+26.5% year-over-year), prompting a +2.84% intraday gain. The company also raised full-year guidance.
Filings2026-06-04+1.7%
MEDP filed a new 8-K on 2026-06-04.
Upcoming catalysts & outlook
Next earnings
2026-07-22 (est.)
in 2 days
10-Q Filing (est.)
2026-07-23
Medium impact
Thesis shift
Neutral / Mixed
bearish signal
Risk level
Medium
from change events

Frequently asked questions about MEDP

Why did Medpace Holdings, Inc. (MEDP) stock move?

MEDP fell 0.6% to $534.54. The move coincided with the context summarized above, though no single company-specific catalyst was independently confirmed.

How much did MEDP stock fall?

MEDP lost 0.59% ($3.19) versus the prior close of $537.73, last trading at $534.54 on 0.3× average volume.

When is Medpace Holdings, Inc.'s next earnings date?

MEDP's next earnings report is estimated for 2026-07-22 — about 2 days away.

What is the analyst price target for MEDP?

The consensus analyst price target for MEDP is $503.00, about 5.9% below the current $534.54. Over the past 90 days, analysts recorded 0 upgrades, 5 maintains, and 2 downgrades.

How BestStocks tracks MEDP

This page is generated automatically by BestStocks' change-detection system after its price and volume cleared MEDP-specific materiality thresholds, triggering an evidence check. It draws on 6 tracked change events for MEDP, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 20, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.

Data sources
FMP real-time & historical price dataSEC EDGAR filingsFMP earnings & estimatesAnalyst ratings & price targets (FMP)Earnings calendar (FMP)
Educational research tool — not personalized investment advice. Data may be delayed.